ERBB2 mutations and association with molecular phenotype in urothelial carcinoma

被引：0
|
作者：
Machaalani, Marc
El Zarif, Talal
Stockhammer, Paul
Semaan, Karl
Eid, Marc
Chehade, Razane El Hajj
Nawfal, Rashad
Yekeduz, Emre
Nassar, Amin
Lee, Gwo-Shu Mary
Baca, Sylvan C.
Choueiri, Toni K.
Grant, Michael J.
Bellmunt, Joaquim
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Yale Univ, Dept Internal Med, Sch Med, New Haven, CT USA
[3] Yale Sch Med, New Haven, CT USA
[4] Yale Canc Ctr, New Haven, CT USA
[5] Yale Univ, New Haven, CT USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4590
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Activating mutations in ERBB2 and their diagnostics and treatment
    Herter-Sprie, Grit S.
    Greulich, Heidi
    Wong, Kwok-Kin
    FRONTIERS IN ONCOLOGY, 2013, 3
  • [22] Modulation of ErbB2 Blockade in ErbB2-Positive Cancers: The Role of ErbB2 Mutations and PHLDA1
    Li, Guangyuan
    Wang, Xiaoqi
    Hibshoosh, Hanina
    Jin, Cheng
    Halmos, Balazs
    PLOS ONE, 2014, 9 (09):
  • [23] The genomic landscape of urothelial carcinoma with high and low ERBB2/HER2 expression.
    Hadadi, Agreen
    Krause, Harris
    Elliott, Andrew
    Farrell, Alex Patrick
    Brown, Jacqueline T.
    Nazha, Bassel
    Harik, Lara
    Carthon, Bradley Curtis
    Nabhan, Chadi
    Barata, Pedro C.
    Saleh, Mohamed
    Yang, Yuanquan
    Korn, W. Michael
    Mckay, Rana R.
    Bilen, Mehmet Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [24] Targetable ERBB2 mutations independently predict an aggressive phenotype in primary, ERBB2 non-amplified, hormone receptor positive lobular breast cancer
    Kurozumi, Sasagu
    Green, Andrew R.
    Ellis, Ian O.
    Rakha, Emad A.
    Fujii, Takaaki
    Shirabe, Ken
    Heery, David
    Zwart, Wilbert
    Oesterreich, Steffi
    Johnston, Simon J.
    CANCER RESEARCH, 2020, 80 (04)
  • [25] A High Frequency of Activating Extracellular Domain ERBB2 (HER2) Mutation in Micropapillary Urothelial Carcinoma
    Ross, Jeffrey S.
    Wang, Kai
    Gay, Laurie M.
    Al-Rohil, Rami N.
    Nazeer, Tipu
    Sheehan, Christine E.
    Jennings, Timothy A.
    Otto, Geoff A.
    Donahue, Amy
    He, Jie
    Palmer, Gary
    Ali, Siraj
    Nahas, Michelle
    Young, Geneva
    LaBrecque, Elaine
    Frampton, Garrett
    Erlich, Rachel
    Curran, John A.
    Brennan, Kristina
    Downing, Sean R.
    Yelensky, Roman
    Lipson, Doron
    Hawryluk, Matthew
    Miller, Vincent A.
    Stephens, Philip J.
    CLINICAL CANCER RESEARCH, 2014, 20 (01) : 68 - 75
  • [26] Oncogenic extracellular domain mutations of ERBB2 in cancer
    Greulich, Heidi
    Kaplan, Bethany
    Mertins, Philipp
    Chen, Tzu-Hsiu
    Tanaka, Kumiko
    Yun, Cai-Hong
    Imielinski, Marcin
    Banerji, Shanatanu
    Lawrence, Michael S.
    Walker, Sarah
    Winckler, Wendy
    Getz, Gad
    Frank, David
    Eck, Michael
    Jaffe, Jacob D.
    Carr, Steven A.
    Wong, Kwok-Kin
    Meyerson, Matthew
    CANCER RESEARCH, 2012, 72
  • [27] Effect of Erbb2 Missense Mutations on Dimer Formation
    Cano, Tayde Gabriela Serrano
    Yasari, Atena
    Tiemann-Boege, Irene
    Nagy, Peter
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2023, 52 (SUPPL 1): : S105 - S105
  • [28] Identification of a novel, brain penetrant, EGFR sparing, ErbB2 inhibitor with activity against oncogenic ErbB2 mutations
    Chicarelli, Mark J.
    Arwood-Levine, Ben
    Bettendorf, Tanna
    Bouhana, Karyn
    Brizendine, Richard
    Cable, LouAnn
    Crow, Michelle
    Fell, Brad
    Fischer, John
    Fulton, Jennifer
    Guarnieri, Anna
    Hillman, Madison
    Jalluri, Ravi
    Krischlunas, Daniel
    Koch, Keith
    Kumar, Vijay
    Malinky, Cori
    Rieger, Rob
    Robinson, John
    Stunkard, Lee
    Sullivan, Francis
    Turton, Roy
    Vine, Logan
    Winski, Shannon
    Zhou, Yeyun
    CANCER RESEARCH, 2024, 84 (09)
  • [29] Metastatic urothelial carcinoma harboring ERBB2/3 mutations dramatically respond to chemotherapy plus anti-PD-1 antibody: A case report
    Yan, Fei-Fei
    Jiang, Qi
    Ru, Bin
    Fei, Xiao-Jie
    Ruan, Jian
    Zhang, Xiao-Chen
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (08) : 2497 - 2503
  • [30] High Frequency of ERBB2 Activating Mutations in Invasive Lobular Breast Carcinoma with Pleomorphic Features
    Manuel Rosa-Rosa, Juan
    Caniego-Casas, Tamara
    Leskela, Susanna
    Cristobal, Eva
    Gonzalez-Martinez, Silvia
    Moreno-Moreno, Esther
    Lopez-Miranda, Elena
    Holgado, Esther
    Perez-Mies, Belen
    Garrido, Pilar
    Palacios, Jose
    CANCERS, 2019, 11 (01)
12345